Cyclenium offers partners for their own targets access to its proprietary CMRT drug discovery technology and QUEST Library, hit generation, and extensive expertise in optimization to clinical candidates. In addition:
Cyclenium is seeking partners with interest in the development of its advanced lead programs:
For additional information please contact our parent company, SpiroChem.
Cyclenium also welcomes inquiries from researchers with interesting early-stage discovery and development opportunities, particularly in the fields of oncology, anti-infectives, inflammation and pain.
Please contact our parent company, SpiroChem, for further discussions.